| Kaci L Morris, DPT | |
|
9 Balmoral Dr Ste A, Poplarville, MS 39470-3344 | |
| (601) 746-5101 | |
| (601) 746-5102 |
| Full Name | Kaci L Morris |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 5 Years |
| Location | 9 Balmoral Dr Ste A, Poplarville, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538792064 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bright Steps Therapy, Llc | 6709276090 | 5 |
News Archive
A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.
There is a growing global consensus that girls are central to global development. Yet issues relating to girls' sexuality and their sexual and reproductive rights continue to be largely neglected. Girls Decide, a new initiative from the International Planned Parenthood Federation (IPPF), highlights the importance of girls' and young women's sexual and reproductive lives for both individual and global development, and aims to ensure governments around the world to adopt policies that work for girls.
Women face a 20 per cent higher risk than men of dying or having heart failure during the five years following a heart attack, according to a new study from University of Alberta cardiology researchers.
CTI Life Sciences announced today the first closing of its second venture capital fund ("CTI II"), with C$134 million of capital now available for investment. The new fund includes reaffirmed support from CTI's existing Québec institutional investors along with new investors Teralys Capital and BDC Capital via the Government of Canada's Venture Capital Action Plan.
Sigma-Aldrich Corporation today announced that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first-ever reference solutions for qualitative evaluation of drug interferences in a testing laboratory's analytical methods.
› Verified 2 days ago
| Provider Name | Bright Steps Therapy, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1245857978 PECOS PAC ID: 6709276090 Enrollment ID: O20211130002091 |
News Archive
A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.
There is a growing global consensus that girls are central to global development. Yet issues relating to girls' sexuality and their sexual and reproductive rights continue to be largely neglected. Girls Decide, a new initiative from the International Planned Parenthood Federation (IPPF), highlights the importance of girls' and young women's sexual and reproductive lives for both individual and global development, and aims to ensure governments around the world to adopt policies that work for girls.
Women face a 20 per cent higher risk than men of dying or having heart failure during the five years following a heart attack, according to a new study from University of Alberta cardiology researchers.
CTI Life Sciences announced today the first closing of its second venture capital fund ("CTI II"), with C$134 million of capital now available for investment. The new fund includes reaffirmed support from CTI's existing Québec institutional investors along with new investors Teralys Capital and BDC Capital via the Government of Canada's Venture Capital Action Plan.
Sigma-Aldrich Corporation today announced that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first-ever reference solutions for qualitative evaluation of drug interferences in a testing laboratory's analytical methods.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kaci L Morris, DPT Po Box 956, Poplarville, MS 39470-0956 Ph: (601) 746-5101 | Kaci L Morris, DPT 9 Balmoral Dr Ste A, Poplarville, MS 39470-3344 Ph: (601) 746-5101 |
News Archive
A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.
There is a growing global consensus that girls are central to global development. Yet issues relating to girls' sexuality and their sexual and reproductive rights continue to be largely neglected. Girls Decide, a new initiative from the International Planned Parenthood Federation (IPPF), highlights the importance of girls' and young women's sexual and reproductive lives for both individual and global development, and aims to ensure governments around the world to adopt policies that work for girls.
Women face a 20 per cent higher risk than men of dying or having heart failure during the five years following a heart attack, according to a new study from University of Alberta cardiology researchers.
CTI Life Sciences announced today the first closing of its second venture capital fund ("CTI II"), with C$134 million of capital now available for investment. The new fund includes reaffirmed support from CTI's existing Québec institutional investors along with new investors Teralys Capital and BDC Capital via the Government of Canada's Venture Capital Action Plan.
Sigma-Aldrich Corporation today announced that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first-ever reference solutions for qualitative evaluation of drug interferences in a testing laboratory's analytical methods.
› Verified 2 days ago
Shannon Mcintosh, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9 Balmoral Dr Ste A, Poplarville, MS 39470 Phone: 601-746-5101 Fax: 601-746-5102 | |
Ms. Brittney Roberts Tynes, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 411 W North St, Poplarville, MS 39470 Phone: 601-795-2130 Fax: 601-795-2164 | |
Mr. Marcus Houston, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 9 Balmoral Dr Ste A, Poplarville, MS 39470 Phone: 601-365-9868 | |
Poplarville Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 1403 S Main St Ste E, Poplarville, MS 39470 Phone: 601-795-6618 Fax: 601-795-6669 | |
Beth E. Breland, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 411 W North St, Poplarville, MS 39470 Phone: 601-795-2130 Fax: 601-795-2164 | |
Ryan W Woods, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1403 South Main Street,, Suite E, Poplarville, MS 39470 Phone: 601-268-5757 Fax: 601-579-5220 |